
September Biotech Meeting Calendar
Tuesday, 1-September-2015
Investor Conferences
Rodman and Renshaw (H.C. Wainwright) - Sept 8-10
FBR Healthcare Conference - Sept 9
Baird Healthcare Conference - Sept 9-10
Citi Biotech Day at Mandarin Oriental - Sept 9-10
Wells Fargo Healthcare - Sept 9-10
BioCentury Newsmakers - Sept 10
Goldman Sachs Biotech Day - Sept 11
Morgan Stanley Global Healthcare - Sept 16-17
Leerink Partners Healthcare Summit - Sept 16-18
BofA Merrill Global Healthcare - Sept 17
Sach Biotech in Europe Forum - Sept 29-30
Leerink Rare Disease Roundtable - Sept 30
Medical Meetings
International Congress on Inborn Errors of Metabolism - Sept 1-4
Spine Society of Europe - Sept 2-4
Sickle Cell Disease Therapeutics Conference - Sept 3
European Congress on Epileptology - Sept 5-9
European Society of Cataract and Refractive Surgery - Sept 5-9
World Conference on Lung Cancer - Sept 6-9
American Association for the Surgery of Trauma - Sept 9-12
American Association of Cardiovascular and Pulmonary Rehab - Sept 10-12
American Society for Surgery of the Hand - Sept 10-12
European Association for the Study of Diabetes - Sept 14-18
Cancer Immunotherapy Conference (CRI-CIMT-EATI-AACR) - Sept 16-19
Interscience Conference on Antimicrobial Agents and Chemo - Sept 18-21
International Myeloma Workshop - Sept 23-26
Clinical Orthopaedic Society - Sept 24-26
ASCO Breast Cancer Symposium - Sept 25-27
European Society of Medical Oncology - Sept 25-29
Cardiovascular and Interventional Radiological Society of Europe - Sept 26-30
Congress of Neurological Surgeons - Sept 26-30
European Respiratory Society - Sept 26-30
American College of Clinical Pharmacy - Sept 27-29
American Neurological Association - Sept 27-29
Heart Failure Society of America - Sept 27-30
American Academy of Otolaryngology and Head & Neck Surgery - Sept 27-30
Phacilitate Cell & Gene Therapy Europe - Sept 29-30
Who Am I?

I'm an individual investor from Kansas City. My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>